Lilly to Participate in UBS Global Healthcare Conference 2022

Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) will participate in the UBS Global Healthcare Conference on May 24, 2022, at 8:30 a.m. ET. Michael Mason, the Senior Vice President and President of Lilly Diabetes, will engage in a fireside chat at the event. A live audio webcast of this presentation will be accessible on Lilly's Investor website, with a replay available for 90 days. Lilly focuses on advancing healthcare solutions, impacting over 47 million people globally through innovative therapies targeting major health challenges. For more details, visit Lilly.com.

INDIANAPOLIS, May 16, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the UBS Global Healthcare Conference on Tuesday, May 24, 2022. Michael Mason, senior vice president, president of Lilly Diabetes, will participate in a fireside chat at 8:30 a.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. F-LLY

Refer to:	Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
	Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-ubs-global-healthcare-conference-2022-301546578.html

SOURCE Eli Lilly and Company

FAQ

What is the date of the UBS Global Healthcare Conference that Eli Lilly will attend?

Eli Lilly will attend the UBS Global Healthcare Conference on May 24, 2022.

Who from Eli Lilly will participate in the fireside chat at the conference?

Michael Mason, Senior Vice President and President of Lilly Diabetes, will participate in the fireside chat.

What time will Eli Lilly's presentation take place at the UBS Global Healthcare Conference?

Eli Lilly's presentation will take place at 8:30 a.m. Eastern Time.

Where can I watch the live audio webcast of Eli Lilly's presentation?

The live audio webcast can be watched on Lilly's Investor website under the 'Webcasts & Presentations' section.

How long will the replay of Eli Lilly's conference presentation be available?

The replay of Eli Lilly's presentation will be available for approximately 90 days.

What health challenges does Eli Lilly focus on addressing?

Eli Lilly focuses on diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers.